ConductScience.org, home

Paper39459407

Amikacin Liposomal Inhalation Suspension for Non-Tuberculous Mycobacteria Lung Infection: A Greek Observational Study.

Loukeri AA and 6 others. Medicina (Kaunas), 2024. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Amikacin Liposomal Inhalation Suspension for Non-Tuberculous Mycobacteria Lung Infection: A Greek Observational Study. Papers, record 39459407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39459407

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amikacin Liposomal Inhalation Suspension for Non-Tuberculous Mycobacteria Lung Infection: A Greek Observational Study.
PubMed
Journal
Medicina (Kaunas)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Observational Study
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
3.06, provisional
iCite
Revised in PubMed
2025-03-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Loukeri AAAngeliki A
2Papathanassiou EEvgenia
3Kavvada AAikaterini
4Kampolis CFChristos F
5Pantazopoulos IIoannishttps://orcid.org/0000-0002-8846-519X
6Moschos CCharalambos
7Papavasileiou AApostoloshttps://orcid.org/0000-0002-5060-2910

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
LiposomesMajor topic
Anti-Bacterial AgentsMajor topic
Humans
Male
Female
Aged
Greece
Administration, Inhalation
Middle Aged
Retrospective Studies
Mycobacterium Infections, Nontuberculous
Lung Diseases
Treatment Outcome
Aged, 80 and over

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130880280M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.Eur Respir J2019https://conductscience.org/library/papers/30880280PubMed
234036184Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.J Clin Tuberc Other Mycobact Dis2021https://conductscience.org/library/papers/34036184PubMed
332322600Clinical Management of Respiratory Adverse Events Associated With Amikacin Liposome Inhalation Suspension: Results From a Patient Survey.Open Forum Infect Dis2020https://conductscience.org/library/papers/32322600PubMed
417277290An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.Am J Respir Crit Care Med2007https://conductscience.org/library/papers/17277290PubMed
528582488Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis.Clin Infect Dis2017https://conductscience.org/library/papers/28582488PubMed
632636299Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.Eur Respir J2020https://conductscience.org/library/papers/32636299PubMed
727748623Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.Am J Respir Crit Care Med2017https://conductscience.org/library/papers/27748623PubMed
828954780Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.Eur Respir J2017https://conductscience.org/library/papers/28954780PubMed
938329686Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine.Infection2024https://conductscience.org/library/papers/38329686PubMed
1030877642Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.Drugs2019https://conductscience.org/library/papers/30877642PubMed
1135924016Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings.Infect Drug Resist2022https://conductscience.org/library/papers/35924016PubMed
1236140237Lipid-Based Drug Delivery Systems for Diseases Managements.Biomedicines2022https://conductscience.org/library/papers/36140237PubMed
1329337230Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule.Food Chem Toxicol2018https://conductscience.org/library/papers/29337230PubMed
1436463137Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings.BMC Pulm Med2022https://conductscience.org/library/papers/36463137PubMed
1533723805Amikacin Liposome Inhalation Suspension in Refractory Mycobacterium avium Complex Lung Disease: A Profile of Its Use.Clin Drug Investig2021https://conductscience.org/library/papers/33723805PubMed
1634541338Challenges of diagnosing and treating non-tuberculous mycobacterial pulmonary disease [NTM-PD]: A case series.J Clin Tuberc Other Mycobact Dis2021https://conductscience.org/library/papers/34541338PubMed
1736244600Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.Int J Infect Dis2022https://conductscience.org/library/papers/36244600PubMed
1823598956The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.Eur Respir J2013https://conductscience.org/library/papers/23598956PubMed
1934289985Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections.Eur Respir Rev2021https://conductscience.org/library/papers/34289985PubMed
2029867826Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages.Front Microbiol2018https://conductscience.org/library/papers/29867826PubMed

See all 25 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42667005Amikacin Liposomal Inhalation Suspension: Advances in Application Against Refractory Mycobacterium avium Complex.Infect Drug Resist2026https://conductscience.org/library/papers/42667005PubMed
42638634Bidirectional pathogenesis between non-tuberculous mycobacteria and bronchiectasis: clinical insights, diagnostic challenges and future directions-Perspectives from South Asia.Front Tuberc2025https://conductscience.org/library/papers/42638634PubMed
42076080
pH-Responsive Nanostructured Calcium Phosphate Microrods as Pulmonary Delivery Platform: Fabrication, Characterization, and Comparative Assessment of Cytotoxic and Transcriptomic Responses in Alveolar Macrophages.
Pharmaceutics2026https://conductscience.org/library/papers/42076080PubMed
41408185Mycobacterium florentinum pulmonary disease: a case report and review of the literature.BMC Infect Dis2025https://conductscience.org/library/papers/41408185PubMed
41304232Epidemiology and Drug Susceptibility of Nontuberculous Mycobacteria in the Province of Pavia (Northern Italy): An Overview.Microorganisms2025https://conductscience.org/library/papers/41304232PubMed
40724029Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections.Antibiotics (Basel)2025https://conductscience.org/library/papers/40724029PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39459407

GET https://conductscience.org/api/papers/v1/39459407/references?page=2